PANEL ENDORSES FLUMIST FOR YOUNG CHILDREN

DECEMBER 01, 2007

The Advisory Committee on Immunization Practices has recommended the flu vaccine FluMist for use in children aged 2 to 5. The recommendation follows an expanded approval of the vaccine?s use in September by the FDA.

The panel said the nasal influenza vaccine is an option and did not favor it over traditional flu shots. Children with a history of asthma or wheezing should get the flu shot, according to the committee members. The panel also voted for a government program that pays for vaccines to extend its FluMist coverage to the younger age group.

FluMist, made by MedImmune Inc, received FDA approval in 2003 for use in children ages 5 and older and in adults up to age 49.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.